Literature DB >> 999448

Drug refusal in schizophrenia and the wish to be crazy.

T Van Putten, E Crumpton, C Yale.   

Abstract

The extremes of drug compliance were studied in two groups of schizophrenics: 29 habitual drug-refusers who invariably discontinued medication only to be readmitted several months later, and 30 drug-complier patients who habitually came in for their refills or injections of antipsychotic medication. The drug-refusers experienced the resurgence of an ego-syntonic grandiose psychosis after they discontinued medication. The habitual compliers, in contrast, developed decompensations characterized by such dysphoric affects as depression, anxiety, virtual absence of grandiosity, and some awareness of illness. The refusal of these chronic schizophrenics to take their medication could not be attributed to social isolation, paranoid diagnosis, or secondary gain. A discriminant function analysis showed grandiosity to be the most powerful discriminating variable between the two groups. We interpret these findings to mean that some schizophrenics may prefer an ego-syntonic grandiose psychosis to a relative drug-induced normality.

Entities:  

Mesh:

Year:  1976        PMID: 999448     DOI: 10.1001/archpsyc.1976.01770120047004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

1.  Conservatorship: an involuntary legal status for 'gravely disabled' mentally disordered persons.

Authors:  J Spensley; P H Werme
Journal:  West J Med       Date:  1979-05

Review 2.  Lack of insight in schizophrenia: impact on treatment adherence.

Authors:  Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A Resnick; William C Wirshing
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Compliance therapy in psychotic patients: randomised controlled trial.

Authors:  R Kemp; P Hayward; G Applewhaite; B Everitt; A David
Journal:  BMJ       Date:  1996-02-10

4.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.

Authors:  Steffen Moritz; Jerome Favrod; Christina Andreou; Anthony P Morrison; Francesca Bohn; Ruth Veckenstedt; Peter Tonn; Anne Karow
Journal:  Schizophr Bull       Date:  2012-02-15       Impact factor: 9.306

Review 5.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

Review 6.  On insight and psychosis: discussion paper.

Authors:  A S David
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000

Review 7.  Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.

Authors:  John G Csernansky; Emily K Schuchart
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  The treatment-resistant patient and the need to stay crazy.

Authors:  L Geisen; E Feuer
Journal:  Psychiatr Q       Date:  1984

Review 9.  The problem of non-compliance with drug therapy.

Authors:  L Evans; M Spelman
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

10.  Denial and acceptance coping styles and medication adherence in schizophrenia.

Authors:  Stephanie Aldebot; Amy G Weisman de Mamani
Journal:  J Nerv Ment Dis       Date:  2009-08       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.